Search results
Author(s):
Birgit Vogel
,
Harriette Van Spall
Added:
2 years ago
In the ESC Congress 2021 episode of the Masterclass video series, host, Dr Harriette Van Spall (McMaster University, CA) meets with Dr Birgit Vogel (Icahn School of Medicine at Mount Sinai, US), one of the commissioners and first author of the "The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030" report.Dr Vogel talks about the rationale of the report. CV…
View more
TRILUMINATE Pivotal Trial Results
Video Series
Author(s):
Victoria Delgado
,
Jose Luis Zamorano
,
Davide Capodanno
,
et al
Added:
1 year ago
In this video series, first presented at the ESC Congress 2022, held in Barcelona, Prof Ralph Stephan von Bardeleben, Prof Jose LuisZamorano, Dr Victoria Delgado, Prof DavideCapodanno and Dr SashaKoul discuss the diagnosis of low flow/low gradient aortic stenosis, which patients gain the most benefit from TAVI and how to avoid heart failure in aortic stenosis patients. Join this international…
View more
Author(s):
Emma Birks
Added:
1 year ago
Author(s):
Brian G Hynes
,
Thomas J Kiernan
,
Nicholas J Ruggiero
,
et al
Added:
3 years ago
Stroke-related morbidity and mortality remain unacceptably high. Recent estimates suggest that it accounts for approximately one out of every 17 deaths in the US, and that a person dies from the direct consequences of stroke every three to four minutes.1 Of the almost 800,000 strokes that occur annually, 87% are ischaemic, the remainder occurring predominantly as a consequence of intracerebral…
View more
Treatment of Bifurcation Coronary Artery Disease with the Dedicated Cappella Sideguard® Stent
Author(s):
Mamas A Mamas
,
Farzin Fath-Ordoubadi
Added:
3 years ago
Article
Author(s):
Roger J Hajjar
Added:
6 years ago
Author(s):
Mohammed Shamim Rahman
,
Ruben de Winter
,
Alex Nap
,
et al
Added:
2 years ago
Author(s):
Samir R Kapadia
,
Stephen G Ellis
,
Nyal Borges
Added:
3 years ago
Obstructive unprotected left main coronary artery (ULMCA) disease has been recognised as a high-risk condition since the 1960s owing to the large quantum of myocardium supplied by this system (see Figure 1). In that era, medical therapy was the only available management and 5-year mortality rates exceeded 60 %.1 With the introduction of coronary artery bypass grafting (CABG) it became clear that…
View more
Author(s):
Aman Ali
,
Timothy A Sanborn
Added:
3 years ago
Cardiogenic shock (CS) remains the leading cause of death among patients hospitalised for acute myocardial infarction (AMI), with mortality rates of approximately 50%.1 Even with the benefit of thrombolytic therapy and intra-aortic balloon pumps (IABPs), the in-hospital mortality rate of patients with CS from AMI was only lowered from 63 to 47% according to a report from the SHould we emergently…
View more